Morning Briefing
Summaries of health policy coverage from major news organizations
Cost Of Hep C Medicines Vexing Insurers
Insurers are issuing their first-quarter results, which reveal a chunk of spending on new Hepatitis C drugs.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
